PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,046,054, 2018 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, V Chelvam, Y Kim, SA Kularatne - US Patent 9,951,324, 2018 - Google Patents
4, 691, 024 A 9/1987 Kunikatsu et al. 4, 713, 249 A 12/1987 Schroder 5, 103, 018 A 4/1992
Motomichi et al. 5, 266, 333 A 11/1993 Cady et al. 5, 418, 982 A 5/1995 Kishi 5, 627, 165 A …
Motomichi et al. 5, 266, 333 A 11/1993 Cady et al. 5, 418, 982 A 5/1995 Kishi 5, 627, 165 A …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,624,970, 2020 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
Conjugates for treating diseases caused by PSMA expressing cells
A6 IK 38/08(2006.01) C07K 5/10(2006.01)(57) ABSTRACT C07K 5/02(2006.01) C07K
5/II(2006.01) The invention described herein pertains to the diagnosis, C07K …
5/II(2006.01) The invention described herein pertains to the diagnosis, C07K …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,517,956, 2019 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,624,971, 2020 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,646,581, 2020 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,485,878, 2019 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,624,969, 2020 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
PSMA binding ligand-linker conjugates and methods for using
PS Low, SA Kularatne - US Patent 10,517,957, 2019 - Google Patents
Described herein are prostate specific membrane antigen (PSMA) binding conjugates that
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …
are useful for delivering therapeutic, diagnostic and imaging agents. Also described herein …